Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Linda Hovanessian-Larsen"'
Autor:
Erin P. Crane, An L Church, Dae Hee Bang, Charlotte Dillis, Bethany L. Niell, Angela DeMichele, Marisa H. Borders, Basak E. Dogan, Jennifer S. Drukteinis, Deepa Sheth, Wei Tse Yang, Stefanie Woodard, Mark A. Rosen, Lisa J. Wilmes, Christina Yau, Natsuko Onishi, David C. Newitt, Theresa Kuritza, Jessica Gibbs, Despina Kontos, Marina E. Giurescu, Ella F. Jones, Thomas L. Chenevert, Mohammad Eghtedari, Roy Harnish, Constance D. Lehman, Fredrik Strand, Vignesh A. Arasu, Bruce Porter, Linda Hovanessian-Larsen, Alex Anh-Tu Nguyen, Elise Berman, Hiroyuki Abe, Mary S. Newell, Neda Jafarian, Laura J. Esserman, Savannah C. Partridge, John Kornak, Kelly Fountain, Luminita A. Tudorica, Donald A. Berry, Patrick J Bolan, Michael Nelson, Sally Goudreau, Kathleen M. Ward, Kimberly A. Fitzpatrick, Karen Y. Oh, Bonnie N. Joe, Lara Hardesty, Kevin Morley, Kathleen R. Brandt, Haydee Ojeda-Fournier, Dan Lopez Paniagua, Heidi Umphrey, Elissa R Price, Elizabeth S. McDonald, Wen Li, Pulin Sheth, Dulcy Wolverton, Nola M. Hylton, Kathryn W Zamora
Publikováno v:
Radiology, vol 301, iss 2
Background Suppression of background parenchymal enhancement (BPE) is commonly observed after neoadjuvant chemotherapy (NAC) at contrast-enhanced breast MRI. It was hypothesized that nonsuppressed BPE may be associated with inferior response to NAC.
Autor:
Mary Yamashita, Rachel F. Brem, Lauren Baker, Taylor F. Mahoney, Patrick Walker, Rachel M. Treat, Linda Hovanessian Larsen
Publikováno v:
Cancer Research. 83:P3-04
Authors: Mary Yamashita, MD; Rachel Brem, MD; Lauren Baker, Ph.D; MD; Taylor Mahoney, PhD; Patrick Walker, PharmD, MPH; Rachel Treat, MA; Linda Hovanessian Larsen, MD. Title: Patient experience with automated SoftVue 3D whole breast tomographic ultra
Autor:
Mary Yamashita, Steven Cen, Bhushan Desai, Linda Hovanessian Larsen, Xiaomeng Lei, Daniel Stahl, Ali Gholamrezanezhad
Publikováno v:
Clinical Imaging
PURPOSE: Racial and ethnic disparities have exacerbated during the COVID-19 pandemic as the healthcare system is overwhelmed. While Hispanics are disproportionately affected by COVID-19, little is known about ethnic disparities in the hospital settin
Imaging of Benign and Malignant Breast Lesions Using Contrast-Enhanced Ultrasound: A Pictorial Essay
Autor:
Sandy C. Lee, Hisham Tchelepi, Nasim Khadem, Bhushan Desai, Mary Yamashita, Linda Hovanessian-Larsen
Publikováno v:
Ultrasound quarterly. 38(1)
Contrast-enhanced ultrasound is a promising noninvasive imaging technique for evaluating benign and malignant breast lesions, as contrast provides information about perfusion and microvasculature. Contrast-enhanced ultrasound is currently off-label u
Autor:
Daniel Stahl, Mary Yamashita, Sandy C Lee, Bhushan Desai, Steven Cen, Linda Hovanessian-Larsen, Xiaomeng Lei
Publikováno v:
Clinical imaging. 80
Objectives This prospective study compares contrast-enhanced spectral mammography (CESM) with contrast-enhanced breast MRI in assessing the extent of newly diagnosed breast cancer in a multiethnic cohort. Methods This study includes 41 patients with
Autor:
Linda Hovanessian-Larsen, Hisham Tchelepi, Sandy C Lee, Bhushan Desai, Edward Grant, Chunqiao Luo, Susan Groshen
Publikováno v:
Journal of Ultrasound in Medicine. 38:2259-2273
Objectives This pilot study evaluated use of contrast-enhanced ultrasound (CEUS) to reduce the number of benign breast masses recommended for biopsy. Methods This prospective study included 131 consenting women, from October 2016 to June 2017, with A
Autor:
Dae Hee Bang, Christina Yau, Stefanie Woodard, Bethany L. Niell, Marisa H. Borders, Savannah C. Partridge, Angela DeMichele, Michael A. Cohen, Jennifer S. Drukteinis, Bruce Porter, Elise Berman, W K Bernreuter, Fredrik Strand, Deepa Sheth, Linda Hovanessian-Larsen, Patrick J. Bolan, Despina Kontos, Vignesh A. Arasu, Michael D. Nelson, Nola M. Hylton, Elizabeth S. McDonald, Alex Anh-Tu Nguyen, Bonnie N. Joe, Natsuko Onishi, Theresa Kuritza, Neda Jafarian, Jessica Gibbs, Wei T. Yang, David C. Newitt, Wen Li, Kelly Fountain, Basak Dogan, Pulin Sheth, Dulcy Wolverton, Kathleen M. Ward, Erin P. Crane, An L Church, Thomas L. Chenevert, John Kornak, Lara A. Hardesty, Dan Lopez-Paniagua, Charlotte Dillis, Ella F. Jones, Lisa J. Wilmes, Karen Y. Oh, Mary S. Newell, Heidi Umphrey, Hiroyuki Abe, Donald A. Berry, Alina Tudorica, Mark A. Rosen, Laura J. Esserman, Marina E. Giurescu, Sally Goudreau, Mohammad Eghtedari, Haydee Ojeda-Fournier, Constance D. Lehman, Kathy R. Brandt, Kevin Morley, Kathryn W. Zamora, Kimberly A. Fitzpatrick, Elissa R. Price
Publikováno v:
NPJ breast cancer, vol 6, iss 1
NPJ Breast Cancer
NPJ Breast Cancer
Dynamic contrast-enhanced (DCE) MRI provides both morphological and functional information regarding breast tumor response to neoadjuvant chemotherapy (NAC). The purpose of this retrospective study is to test if prediction models combining multiple M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50c6a10e0b4b4db3adddb2b166f5834e
https://escholarship.org/uc/item/25w77044
https://escholarship.org/uc/item/25w77044
Autor:
Mary Yamashita, Julie E. Lang, Christy A. Russell, Young Ju Jeong, Linda Hovanessian Larsen, Heather R. Macdonald, Wendy J. Mack, Akshara Singareeka Raghavendra, Stephen F. Sener, Pulin Sheth, Julie S. Wecsler, Debasish Tripathy
Publikováno v:
J Surg Oncol
BACKGROUND. The use of preoperative magnetic resonance imaging (MRI) for newly diagnosed breast cancer remains controversial. We examined factors associated with detection of occult multicentric, multifocal, and contralateral malignant lesions only s
Autor:
Richard Sposto, Linda Hovanessian Larsen, Julie E. Lang, Charité Ricker, Stephen F. Sener, Pulin Sheth, Lingyun Ji, Debu Tripathy, Terry David Church, Akshara Singareeka Raghavendra, Julie S. Wecsler
Publikováno v:
Breast Cancer Res Treat
BACKGROUND: The performance of magnetic resonance imaging (MRI), the effect of patient factors, and resulting surgical management in underserved and ethnically diverse breast cancer (BC) patient populations have been understudied. METHODS: We retrosp
Autor:
Sadia Choudhery, David C. Newitt, Anthony D. Elias, Nola M. Hylton, Constance D. Lehman, Judy C. Boughey, Douglas Yee, William Smith, Laura J. van't Veer, Pulin Sheth, Dulcy Wolverton, Wei Yang, W. Fraser Symmans, Kim Fitzpatrick, Natsuko Onishi, Theresa Kuritza, Julie E. Lang, Richard Schwab, Laura Sit, Thelma Brown, Erica Stringer-Reasor, Jessica Gibbs, Laura J. Esserman, Qamar J. Khan, Jane Perlmutter, Neda Jafarian, Erin D. Ellis, HS Han, Kathy R. Brandt, Kevin Morley, Richard Ha, Kathryn W. Zamora, Elise Berman, Michelle E. Melisko, Mary S. Newell, Sally Goudreau, Michael D. Nelson, Erin P. Crane, An L Church, A. Jo Chien, Rachel L. Yung, Ella F. Jones, Janice Lu, Marina E. Giurescu, Hiroyuki Abe, Elizabeth S. McDonald, Smita Asare, Deepa Sheth, Dae Hee Bang, Mohammad Eghtedari, Kelly Fountain, Ralph Wynn, Stefanie Woodard, Donald W. Northfelt, Elissa R. Price, Rita Nanda, Bethany L. Niell, Marisa H. Borders, Claudine Isaacs, Zaha Mitri, Basak E. Dogan, Donald A. Berry, Rebecca K. Viscusi, Haydee Ojeda-Fornier, Michael A. Cohen, Bonnie N. Joe, Lisa J. Wilmes, Mark A. Rosen, Anne M. Wallace, Kirsten K. Edmiston, Linda Hovanessian-Larsen, Tara Sanft, Wen Li, Kathy S. Albain, Amy S. Clark, David M. Euhus, Angela DeMichele, Jennifer S. Drukteinis, Christiane Mullins, Jane L. Meisel, Hope S. Rugo, Christina Yau, Michael Spektor, Charlotte Dillis, Karen Y Oh
Publikováno v:
Cancer Research. 80:PD9-04
Background: In an adaptive randomized trial, when new treatment combinations are being tested, it is important to be able to identify patients who are progressing on treatment so that they can be changed to a different therapeutic regimen. We know th